CN101594892A - 真皮内注射用透明质酸水凝胶 - Google Patents
真皮内注射用透明质酸水凝胶 Download PDFInfo
- Publication number
- CN101594892A CN101594892A CNA2007800436860A CN200780043686A CN101594892A CN 101594892 A CN101594892 A CN 101594892A CN A2007800436860 A CNA2007800436860 A CN A2007800436860A CN 200780043686 A CN200780043686 A CN 200780043686A CN 101594892 A CN101594892 A CN 101594892A
- Authority
- CN
- China
- Prior art keywords
- kilodaltons
- hyaluronic acid
- implant
- gel
- injectable implant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L5/00—Compositions of polysaccharides or of their derivatives not provided for in groups C08L1/00 or C08L3/00
- C08L5/08—Chitin; Chondroitin sulfate; Hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F2/00—Filters implantable into blood vessels; Prostheses, i.e. artificial substitutes or replacements for parts of the body; Appliances for connecting them with the body; Devices providing patency to, or preventing collapsing of, tubular structures of the body, e.g. stents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/04—Dispersions; Emulsions
- A61K8/042—Gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/72—Cosmetics or similar toiletry preparations characterised by the composition containing organic macromolecular compounds
- A61K8/73—Polysaccharides
- A61K8/735—Mucopolysaccharides, e.g. hyaluronic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/14—Macromolecular materials
- A61L27/20—Polysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/52—Hydrogels or hydrocolloids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/91—Injection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L2400/00—Materials characterised by their function or physical properties
- A61L2400/06—Flowable or injectable implant compositions
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Transplantation (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Birds (AREA)
- Dispersion Chemistry (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Biochemistry (AREA)
- Polymers & Plastics (AREA)
- Cardiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Materials For Medical Uses (AREA)
- Medicinal Preparation (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Prostheses (AREA)
Abstract
Description
Claims (18)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0610645A FR2909560B1 (fr) | 2006-12-06 | 2006-12-06 | Gel d'acide hyaluronique pour injection intradermique |
FR06/10645 | 2006-12-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN101594892A true CN101594892A (zh) | 2009-12-02 |
Family
ID=38198256
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNA2007800436860A Pending CN101594892A (zh) | 2006-12-06 | 2007-12-06 | 真皮内注射用透明质酸水凝胶 |
Country Status (22)
Country | Link |
---|---|
US (1) | US20100316683A1 (zh) |
EP (2) | EP2489374A1 (zh) |
JP (1) | JP5642388B2 (zh) |
KR (2) | KR101642516B1 (zh) |
CN (1) | CN101594892A (zh) |
AR (1) | AR064175A1 (zh) |
AU (1) | AU2007328917B2 (zh) |
BR (1) | BRPI0720176A2 (zh) |
CA (1) | CA2671793A1 (zh) |
ES (1) | ES2632947T3 (zh) |
FR (1) | FR2909560B1 (zh) |
IL (1) | IL199002A (zh) |
MA (1) | MA30978B1 (zh) |
MX (1) | MX2009005894A (zh) |
NO (1) | NO20092465L (zh) |
NZ (1) | NZ577917A (zh) |
RU (1) | RU2448740C2 (zh) |
TN (1) | TN2009000223A1 (zh) |
TW (1) | TWI430815B (zh) |
UA (1) | UA95660C2 (zh) |
WO (1) | WO2008068297A1 (zh) |
ZA (1) | ZA200903919B (zh) |
Cited By (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102905677A (zh) * | 2010-03-12 | 2013-01-30 | 阿勒根工业有限公司 | 用于改善皮肤状况的包含透明质烷聚合物和甘露糖醇的流体组合物 |
CN103181902A (zh) * | 2011-12-30 | 2013-07-03 | 张文芳 | 一种凝胶微球及其质控方法 |
CN104010578A (zh) * | 2011-12-20 | 2014-08-27 | 血管诊疗公司 | 透明质酸及其在治疗静脉功能不全和静脉曲张中的应用 |
CN104086788A (zh) * | 2014-07-17 | 2014-10-08 | 华熙福瑞达生物医药有限公司 | 一种注射用修饰透明质酸钠凝胶 |
CN104395348A (zh) * | 2012-06-15 | 2015-03-04 | 莫茨药物股份两合公司 | 制备基于透明质酸的组合物的方法 |
CN104906030A (zh) * | 2014-03-14 | 2015-09-16 | 台湾生医材料股份有限公司 | 压力敏感性水胶及其使用方法 |
CN105107018A (zh) * | 2015-08-19 | 2015-12-02 | 李媚 | 一种无菌可注射材料的制备方法 |
CN106074213A (zh) * | 2016-06-24 | 2016-11-09 | 上海建华精细生物制品有限公司 | 用于水光注射的透明质酸钠凝胶及其制备方法和应用 |
CN107207784A (zh) * | 2015-02-13 | 2017-09-26 | (株)安道德玛 | 利用交联透明质酸水凝胶的微结构体及其的制造方法 |
CN107223061A (zh) * | 2015-02-13 | 2017-09-29 | 阿勒根工业有限公司 | 用于雕塑、填充或矫正面部特征例如下巴的植入物 |
CN108261341A (zh) * | 2018-02-12 | 2018-07-10 | 苏州纳晶医药技术有限公司 | 双组份用于纠正皮肤皱纹的美白长效水光针剂 |
CN108379112A (zh) * | 2011-09-14 | 2018-08-10 | 阿勒根公司 | 用于细纹治疗的真皮填充剂组合物 |
WO2019033596A1 (zh) * | 2017-08-16 | 2019-02-21 | 杭州协合医疗用品有限公司 | 制备单相修饰透明质酸钠凝胶的方法 |
CN111068114A (zh) * | 2019-12-26 | 2020-04-28 | 浙江景嘉医疗科技有限公司 | 一种含甘露醇的注射用修饰透明质酸钠凝胶的制备方法 |
US11083684B2 (en) | 2011-06-03 | 2021-08-10 | Allergan Industrie, Sas | Dermal filler compositions |
CN115944553A (zh) * | 2022-12-07 | 2023-04-11 | 华熙生物科技股份有限公司 | 寡肽在提高交联透明质酸或其盐稳定性中的应用 |
Families Citing this family (79)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2861734B1 (fr) | 2003-04-10 | 2006-04-14 | Corneal Ind | Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus |
US20080293637A1 (en) | 2007-05-23 | 2008-11-27 | Allergan, Inc. | Cross-linked collagen and uses thereof |
FR2918276B1 (fr) | 2007-07-02 | 2010-01-22 | Anteis Sa | "utilisation d'un gel de polysaccharide(s)naturel(s)pour la preparation d'une formulation injectable de traitement des degenerescences articulaires" |
US20110077737A1 (en) * | 2007-07-30 | 2011-03-31 | Allergan, Inc. | Tunably Crosslinked Polysaccharide Compositions |
US8697044B2 (en) | 2007-10-09 | 2014-04-15 | Allergan, Inc. | Crossed-linked hyaluronic acid and collagen and uses thereof |
BRPI0819075A2 (pt) | 2007-11-16 | 2014-10-07 | Vicept Therapeutics Inc | Método para tratar púrpura em um indivíduo e método para diminuir a púrpura em um indivíduo antes de um procedimento cirúrgico |
US8394784B2 (en) | 2007-11-30 | 2013-03-12 | Allergan, Inc. | Polysaccharide gel formulation having multi-stage bioactive agent delivery |
US8394782B2 (en) | 2007-11-30 | 2013-03-12 | Allergan, Inc. | Polysaccharide gel formulation having increased longevity |
US20100279952A1 (en) * | 2007-12-21 | 2010-11-04 | Ninus Caram-Lelham | Cross-linked hydrogel containing an active substance |
AU2015252122A1 (en) * | 2008-08-04 | 2015-11-26 | Allergan Industrie Sas | Hyaluronic acid-based gels including anesthetic agents |
US8450475B2 (en) | 2008-08-04 | 2013-05-28 | Allergan, Inc. | Hyaluronic acid-based gels including lidocaine |
EP3184552B1 (en) | 2008-09-02 | 2020-08-12 | Tautona Group LP | Threads of hyaluronic acid, methods of making thereof and uses thereof |
FR2938187B1 (fr) * | 2008-11-07 | 2012-08-17 | Anteis Sa | Composition injectable a base d'acide hyaluronique ou l'un de ses sels, de polyols et de lidocaine, sterilisee a la chaleur |
FR2940609B1 (fr) * | 2008-12-30 | 2011-05-06 | Oreal | Association de monosaccharides et d'agents desquamants et son utilisation en cosmetique |
EP2413894B1 (en) * | 2009-04-02 | 2017-01-04 | Allergan, Inc. | Hair-like shaped hydrogels for soft tissue augmentation |
FR2945293B1 (fr) | 2009-05-11 | 2011-06-17 | Teoxane | Procede de preparation d'un gel reticule. |
FR2945949B1 (fr) | 2009-05-26 | 2011-05-13 | Anteis Sa | Hydrogel injectable permettant une supplementation en glycerol dans la peau sur le long terme. |
IT1395392B1 (it) * | 2009-08-27 | 2012-09-14 | Fidia Farmaceutici | Geli viscoelastici come nuovi filler |
US20110171310A1 (en) * | 2010-01-13 | 2011-07-14 | Allergan Industrie, Sas | Hydrogel compositions comprising vasoconstricting and anti-hemorrhagic agents for dermatological use |
US20110172180A1 (en) | 2010-01-13 | 2011-07-14 | Allergan Industrie. Sas | Heat stable hyaluronic acid compositions for dermatological use |
US9114188B2 (en) | 2010-01-13 | 2015-08-25 | Allergan, Industrie, S.A.S. | Stable hydrogel compositions including additives |
AU2015255189B2 (en) * | 2010-03-12 | 2017-05-25 | Allergan Industrie Sas | A fluid composition comprising a hyaluronan polymer and mannitol for improving skin condition |
AU2011229730B2 (en) | 2010-03-22 | 2016-01-07 | Allergan, Inc. | Polysaccharide and protein-polysaccharide cross-linked hydrogels for soft tissue augmentation |
WO2012008722A2 (ko) * | 2010-07-12 | 2012-01-19 | 신풍제약 주식회사 | 조직 증강용 충전 조성물 |
US8697057B2 (en) | 2010-08-19 | 2014-04-15 | Allergan, Inc. | Compositions and soft tissue replacement methods |
US8883139B2 (en) | 2010-08-19 | 2014-11-11 | Allergan Inc. | Compositions and soft tissue replacement methods |
US9005605B2 (en) | 2010-08-19 | 2015-04-14 | Allergan, Inc. | Compositions and soft tissue replacement methods |
US8889123B2 (en) | 2010-08-19 | 2014-11-18 | Allergan, Inc. | Compositions and soft tissue replacement methods |
PT2637710T (pt) * | 2010-11-08 | 2017-07-12 | Allergan Ind Sas | Formulações à base de ácido hialurónico |
PL3138586T3 (pl) * | 2010-11-08 | 2021-09-13 | Allergan Industrie, Sas | Wypełniacz tkanki miękkiej |
EP2484387A1 (en) * | 2011-02-03 | 2012-08-08 | Q-Med AB | Hyaluronic acid composition |
EP3536307B1 (en) * | 2011-06-03 | 2021-10-20 | ALLERGAN Industrie, SAS | Dermal filler compositions including antioxidants |
US9393263B2 (en) | 2011-06-03 | 2016-07-19 | Allergan, Inc. | Dermal filler compositions including antioxidants |
US9408797B2 (en) | 2011-06-03 | 2016-08-09 | Allergan, Inc. | Dermal filler compositions for fine line treatment |
US9662422B2 (en) | 2011-09-06 | 2017-05-30 | Allergan, Inc. | Crosslinked hyaluronic acid-collagen gels for improving tissue graft viability and soft tissue augmentation |
US20130244943A1 (en) | 2011-09-06 | 2013-09-19 | Allergan, Inc. | Hyaluronic acid-collagen matrices for dermal filling and volumizing applications |
WO2013092872A2 (en) * | 2011-12-22 | 2013-06-27 | L'oreal | Cosmetic processes with glucosamine-based hydrogels |
FR2994846B1 (fr) | 2012-08-29 | 2014-12-26 | Vivacy Lab | Composition, sterilisee, comprenant au moins un acide hyaluronique et de l'ascorbyl phosphate de magnesium |
CN102863631B (zh) * | 2012-09-29 | 2013-11-13 | 杭州嘉伟生物制品有限公司 | 外科整形用组织填充剂交联透明质酸钠凝胶及其制备方法 |
CN103006544B (zh) * | 2012-12-21 | 2014-07-09 | 上海景峰制药股份有限公司 | 一种高粘弹性玻璃酸钠凝胶制备方法 |
US20140315828A1 (en) | 2013-04-22 | 2014-10-23 | Allergan, Inc. | Cross-linked silk-hyaluronic acid compositions |
WO2015018461A1 (fr) | 2013-08-09 | 2015-02-12 | Genbiotech | Compositions therapeutiques comprenant d'acide hyaluronique |
US9757330B2 (en) | 2013-10-18 | 2017-09-12 | Industrial Technology Research Institute | Recipe for in-situ gel, and implant, drug delivery system formed thereby |
WO2015125117A1 (en) * | 2014-02-20 | 2015-08-27 | Mastelli S.R.L. | Dermocosmetic filler and uses thereof for aesthetic purposes |
AR099900A1 (es) | 2014-04-01 | 2016-08-24 | Merz Pharma Gmbh & Co Kgaa | Rellenos para tejidos blandos con polisacáridos con persistencia mejorada, kit, procedimiento, uso |
FR3020570B1 (fr) * | 2014-04-30 | 2017-07-21 | Pierre Fabre Dermo-Cosmetique | Association d'un acide hyaluronique et d'un polysaccharide sulfate |
KR101641299B1 (ko) * | 2014-06-25 | 2016-07-20 | 김동진 | 금속 코팅 가시매선 |
EP3200838B1 (en) | 2014-09-30 | 2019-09-18 | Allergan Industrie, SAS | Stable hydrogel compositions including additives |
FR3029928B1 (fr) | 2014-12-15 | 2018-03-09 | Teoxane | Gel reticule |
WO2016128783A1 (en) | 2015-02-09 | 2016-08-18 | Allergan Industrie Sas | Compositions and methods for improving skin appearance |
FR3036035B1 (fr) * | 2015-05-11 | 2018-10-05 | Laboratoires Vivacy | Compositions comprenant au moins un polyol et au moins un anesthesique |
US10004824B2 (en) | 2015-05-11 | 2018-06-26 | Laboratoires Vivacy | Compositions comprising at least one polyol and at least one anesthetic |
FR3037797B1 (fr) | 2015-06-24 | 2018-08-17 | Kylane Laboratoires Sa | Procede de preparation d'un hydrogel reticule injectable; hydrogel obtenu; utilisation de l'hydrogel obtenu |
ES2836473T3 (es) | 2015-06-30 | 2021-06-25 | Merz Pharma Gmbh & Co Kgaa | Método de preparación de una composición basada en ácido hialurónico |
EP3328351A1 (en) | 2015-07-27 | 2018-06-06 | Galderma S.A. | A process for efficient cross-linking of hyaluronic acid |
JP2018522051A (ja) * | 2015-08-06 | 2018-08-09 | ラボラトリ デリバティ オルガニチ スパ | デルマタン硫酸とコンドロイチン硫酸とを含む組成物および美容組成物におけるその使用 |
EP3165233B1 (en) * | 2015-08-28 | 2021-08-18 | Latvijas Universitate | Biomaterial for treatment of acute and chronic skin wounds |
RU2697671C1 (ru) * | 2015-11-24 | 2019-08-16 | БиЭмАй КОРЕЯ КО., ЛТД | Композиция для инъекций гиалуроновой кислоты, содержащей производное гиалуроновой кислоты и ДНК фракцию, и ее применение |
TWI727014B (zh) | 2016-03-24 | 2021-05-11 | 德商梅茲製藥有限兩合公司 | 修飾透明質酸與其製造方法及其用途 |
CA2961868A1 (en) * | 2016-04-08 | 2017-10-08 | Johnson & Johnson Consumer Inc. | Topical compositions containing cross-linked glycosaminoglycans |
KR101660211B1 (ko) * | 2016-06-07 | 2016-09-26 | 동국제약 주식회사 | 단일상과 이성상의 특성을 동시에 갖는 히알루론산 가교체, 이의 제조 방법 및 이의 용도 |
BR112018075703A2 (pt) | 2016-06-16 | 2019-04-02 | Endoderma Co., Ltd. | microestrutura do ácido hialurônico tendo exce-lentes características de solubilidade |
WO2018039496A1 (en) | 2016-08-24 | 2018-03-01 | Allergan, Inc. | Co-crosslinked hyaluronic acid-silk fibroin hydrogels for improving tissue graft viability and for soft tissue augmentation |
FR3058064B1 (fr) | 2016-10-28 | 2020-08-07 | Lab Vivacy | Composition a base d'acide hyaluronique comprenant de la mepivacaine |
KR20180055938A (ko) * | 2016-11-09 | 2018-05-28 | 김주홍 | 주름 제거용 패치 |
KR101718483B1 (ko) | 2016-12-21 | 2017-04-05 | 주식회사 동방메디컬 | 니들 패치의 제조방법 및 이 방법으로 제조된 니들 패치 |
KR101921246B1 (ko) * | 2017-01-04 | 2018-11-22 | 주식회사 베스트앤퍼스트바이오텍 | 탈모 방지 및 양모를 위한 헤어 필러 조성물 및 그 제조 방법 |
BR112019017795B1 (pt) * | 2017-02-28 | 2022-12-06 | Cg Bio Co., Ltd. | Composição para injeção dérmica |
CN112334165A (zh) * | 2018-06-15 | 2021-02-05 | 克罗马药品有限责任公司 | 稳定化的透明质酸 |
US20210260244A1 (en) | 2018-06-29 | 2021-08-26 | Merz Pharma Gmbh & Co. Kgaa | Fatty acid-grafted hyaluronic acid, dermal filler formulations comprising same, process for preparation and use thereof |
KR102392812B1 (ko) * | 2018-07-06 | 2022-04-29 | 주식회사 엘지화학 | 높은 점탄성 및 응집성을 동시에 갖는 히알루론산 필러 |
WO2020030629A1 (en) | 2018-08-07 | 2020-02-13 | Merz Pharma Gmbh & Co. Kgaa | Method for dynamic filtration of a cross-linked hydrogel |
CA3122116C (en) * | 2018-12-20 | 2023-07-18 | Lg Chem, Ltd. | Filler having excellent filler properties comprising hyaluronic acid hydrogel |
EP3946246A4 (en) * | 2019-03-24 | 2023-06-21 | Allergan Pharmaceuticals International Limited | INJECTABLE HOMOGENEOUS JELLS WITH SEVERAL FORMS OF HYALURONIC ACID AND PROCESS FOR THEIR PREPARATION |
RU2731527C1 (ru) * | 2020-01-28 | 2020-09-03 | Кирилл Александрович Новиков | Способ устранения рубцовых изменений кожи |
BR102020003483A2 (pt) * | 2020-02-19 | 2021-08-31 | Marco Antonio Bittencourt | Implantes subcutâneos para liberação lenta e controlada de ativos. |
FR3128373A1 (fr) | 2021-10-22 | 2023-04-28 | Jr | Composition pour son utilisation dans la synthese cutanee d’acide hyaluronique, dans la reponse immuno-cutanee et une amelioration de la peau |
WO2023172037A1 (ko) * | 2022-03-11 | 2023-09-14 | 주식회사 제네웰 | 페이스트 조성물, 생분해성 주사용 페이스트 및 이의 제조방법 |
DE102022113526A1 (de) * | 2022-05-30 | 2023-11-30 | Louna Aesthetics SAS | Verfahren zur Herstellung einer Zusammensetzung, Zusammensetzung und Verwendung der Zusammensetzung |
Citations (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5399351A (en) * | 1990-07-09 | 1995-03-21 | Biomatrix, Inc. | Biocompatible viscoelastic gel slurries, their preparation and use |
WO1996033751A1 (fr) * | 1995-04-25 | 1996-10-31 | W.K. Et Associes | Compositions biphasiques injectables renfermant de l'acide hyaluronique, notamment utiles en chirurgies reparatrice et esthetique |
FR2733427A1 (fr) * | 1995-04-25 | 1996-10-31 | W K Et Associes | Compositions biphasiques injectables renfermant de l'acide hyaluronique, notamment utiles en chirurgies reparatrice et esthetique |
FR2778336A1 (fr) * | 1998-05-11 | 1999-11-12 | Jean Pierre Perraud | Implant injectable en sous-cutane et en sous-gingival resorbable a base de maltodextrine micro-encapsulee et resorbable en un temps determine |
WO2000027887A2 (en) * | 1998-11-11 | 2000-05-18 | Aquisitio S.P.A. | Cross-linked hyaluronic acids and medical uses thereof |
WO2004092222A2 (fr) * | 2003-04-10 | 2004-10-28 | Corneal Industrie | Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus; |
US20050281880A1 (en) * | 2004-05-20 | 2005-12-22 | Wei Wang | Methods for making injectable polymer hydrogels |
WO2006021644A1 (fr) * | 2004-07-23 | 2006-03-02 | Asius Jerome | Acide hyaluronique reticule soluble dans l'eau, son procede de preparation, implant contenant ledit acide hyaluronique reticule, et son utilisation |
WO2006097806A1 (fr) * | 2005-03-14 | 2006-09-21 | Aldivia | Antioxydants a base d'especes d'anacardiacees, leurs procedes d'obtention et leurs applications |
Family Cites Families (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE442820B (sv) * | 1984-06-08 | 1986-02-03 | Pharmacia Ab | Gel av tverbunden hyaluronsyra for anvendning som glaskroppssubstitut |
US5143724A (en) * | 1990-07-09 | 1992-09-01 | Biomatrix, Inc. | Biocompatible viscoelastic gel slurries, their preparation and use |
IE912365A1 (en) * | 1990-07-23 | 1992-01-29 | Zeneca Ltd | Continuous release pharmaceutical compositions |
US5143744A (en) * | 1991-06-19 | 1992-09-01 | Minnesota Mining And Manufacturing Company | Dynamic contact angle measurement system |
JPH11279042A (ja) | 1998-03-30 | 1999-10-12 | Shiseido Co Ltd | 皮膚外用剤 |
FR2780730B1 (fr) * | 1998-07-01 | 2000-10-13 | Corneal Ind | Compositions biphasiques injectables, notamment utiles en chirurgies reparatrice et esthetique |
FR2811996B1 (fr) * | 2000-07-19 | 2003-08-08 | Corneal Ind | Reticulation de polysaccharide(s), preparation d'hydrogel(s) ; polysaccharide(s) et hydrogel(s) obtenus,leurs utilisations |
US7820194B2 (en) * | 2001-12-21 | 2010-10-26 | Alcon, Inc. | Combinations of viscoelastics for use during surgery |
US20040092222A1 (en) * | 2002-11-07 | 2004-05-13 | Bogdan Kowalczyk | Stationary head for a disc-type coin processing device having a solid lubricant disposed thereon |
FR2850282B1 (fr) * | 2003-01-27 | 2007-04-06 | Jerome Asius | Implant injectable a base de ceramique pour le comblement de rides, depressions cutanees et cicatrices, et sa preparation |
AU2003206922A1 (en) * | 2003-02-19 | 2004-09-09 | Aventis Pharmaceuticals Holdings Inc. | Composition and method for intradermal soft tissue augmentation |
AU2003901834A0 (en) * | 2003-04-17 | 2003-05-01 | Clearcoll Pty Ltd | Cross-linked polysaccharide compositions |
GB0329907D0 (en) * | 2003-12-23 | 2004-01-28 | Innomed Ltd | Compositions |
US20050142152A1 (en) | 2003-12-30 | 2005-06-30 | Leshchiner Adelya K. | Polymeric materials, their preparation and use |
FR2865651B1 (fr) | 2004-01-29 | 2007-09-28 | Fabre Pierre Dermo Cosmetique | Compositions topiques associant des fragments de hyaluronate de sodium et un retinoide utiles en dermatologie cosmetique et medicale |
FR2865737B1 (fr) | 2004-02-03 | 2006-03-31 | Anteis Sa | Gel reticule biocompatible |
KR100648515B1 (ko) * | 2004-05-04 | 2006-11-27 | (주)아모레퍼시픽 | 비스포스포네이트-함유 고분자 미립구를 포함하는 골-관련질환 치료 또는 예방용 서방 효과를 갖는 주사제 |
CN101056891B (zh) * | 2004-11-15 | 2010-05-26 | 株式会社资生堂 | 交联透明质酸凝胶的制备方法 |
US20060105022A1 (en) * | 2004-11-15 | 2006-05-18 | Shiseido Co., Ltd. | Process for preparing crosslinked hyaluronic acid gel |
US8481080B2 (en) * | 2004-11-24 | 2013-07-09 | Novozymes Biopolymer A/S | Method of cross-linking hyaluronic acid with divinulsulfone |
-
2006
- 2006-12-06 FR FR0610645A patent/FR2909560B1/fr not_active Expired - Fee Related
-
2007
- 2007-12-05 TW TW096146308A patent/TWI430815B/zh not_active IP Right Cessation
- 2007-12-06 EP EP12168352A patent/EP2489374A1/fr not_active Withdrawn
- 2007-12-06 US US12/517,862 patent/US20100316683A1/en not_active Abandoned
- 2007-12-06 WO PCT/EP2007/063384 patent/WO2008068297A1/fr active Application Filing
- 2007-12-06 EP EP07847872.4A patent/EP2152329B1/fr not_active Revoked
- 2007-12-06 CN CNA2007800436860A patent/CN101594892A/zh active Pending
- 2007-12-06 ES ES07847872.4T patent/ES2632947T3/es active Active
- 2007-12-06 UA UAA200906920A patent/UA95660C2/ru unknown
- 2007-12-06 KR KR1020097012173A patent/KR101642516B1/ko active IP Right Grant
- 2007-12-06 KR KR1020147022209A patent/KR101642622B1/ko active IP Right Grant
- 2007-12-06 BR BRPI0720176-1A2A patent/BRPI0720176A2/pt not_active IP Right Cessation
- 2007-12-06 CA CA002671793A patent/CA2671793A1/fr not_active Abandoned
- 2007-12-06 MX MX2009005894A patent/MX2009005894A/es active IP Right Grant
- 2007-12-06 NZ NZ577917A patent/NZ577917A/en not_active IP Right Cessation
- 2007-12-06 RU RU2009125201/15A patent/RU2448740C2/ru not_active IP Right Cessation
- 2007-12-06 AU AU2007328917A patent/AU2007328917B2/en not_active Ceased
- 2007-12-06 JP JP2009539751A patent/JP5642388B2/ja not_active Expired - Fee Related
- 2007-12-06 AR ARP070105470A patent/AR064175A1/es unknown
-
2009
- 2009-05-27 IL IL199002A patent/IL199002A/en not_active IP Right Cessation
- 2009-06-03 TN TNP2009000223A patent/TN2009000223A1/fr unknown
- 2009-06-05 ZA ZA200903919A patent/ZA200903919B/xx unknown
- 2009-06-09 MA MA31968A patent/MA30978B1/fr unknown
- 2009-06-30 NO NO20092465A patent/NO20092465L/no not_active Application Discontinuation
Patent Citations (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5399351A (en) * | 1990-07-09 | 1995-03-21 | Biomatrix, Inc. | Biocompatible viscoelastic gel slurries, their preparation and use |
WO1996033751A1 (fr) * | 1995-04-25 | 1996-10-31 | W.K. Et Associes | Compositions biphasiques injectables renfermant de l'acide hyaluronique, notamment utiles en chirurgies reparatrice et esthetique |
FR2733427A1 (fr) * | 1995-04-25 | 1996-10-31 | W K Et Associes | Compositions biphasiques injectables renfermant de l'acide hyaluronique, notamment utiles en chirurgies reparatrice et esthetique |
FR2778336A1 (fr) * | 1998-05-11 | 1999-11-12 | Jean Pierre Perraud | Implant injectable en sous-cutane et en sous-gingival resorbable a base de maltodextrine micro-encapsulee et resorbable en un temps determine |
WO2000027887A2 (en) * | 1998-11-11 | 2000-05-18 | Aquisitio S.P.A. | Cross-linked hyaluronic acids and medical uses thereof |
WO2004092222A2 (fr) * | 2003-04-10 | 2004-10-28 | Corneal Industrie | Reticulation de polysaccharides de faible et forte masse moleculaire; preparation d'hydrogels monophasiques injectables; polysaccharides et hydrogels obtenus; |
US20060194758A1 (en) * | 2003-04-10 | 2006-08-31 | Pierre Lebreton | Cross-linking of low and high molecular weight polysaccharides preparation of injectable monophase hydrogels and polysaccharides and dydrogels thus obtained |
US20050281880A1 (en) * | 2004-05-20 | 2005-12-22 | Wei Wang | Methods for making injectable polymer hydrogels |
WO2006021644A1 (fr) * | 2004-07-23 | 2006-03-02 | Asius Jerome | Acide hyaluronique reticule soluble dans l'eau, son procede de preparation, implant contenant ledit acide hyaluronique reticule, et son utilisation |
WO2006097806A1 (fr) * | 2005-03-14 | 2006-09-21 | Aldivia | Antioxydants a base d'especes d'anacardiacees, leurs procedes d'obtention et leurs applications |
Cited By (21)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102905677A (zh) * | 2010-03-12 | 2013-01-30 | 阿勒根工业有限公司 | 用于改善皮肤状况的包含透明质烷聚合物和甘露糖醇的流体组合物 |
US11083684B2 (en) | 2011-06-03 | 2021-08-10 | Allergan Industrie, Sas | Dermal filler compositions |
CN108379112A (zh) * | 2011-09-14 | 2018-08-10 | 阿勒根公司 | 用于细纹治疗的真皮填充剂组合物 |
CN104010578A (zh) * | 2011-12-20 | 2014-08-27 | 血管诊疗公司 | 透明质酸及其在治疗静脉功能不全和静脉曲张中的应用 |
CN103181902A (zh) * | 2011-12-30 | 2013-07-03 | 张文芳 | 一种凝胶微球及其质控方法 |
CN103181902B (zh) * | 2011-12-30 | 2016-06-08 | 张文芳 | 一种凝胶微球及其质控方法 |
CN104395348A (zh) * | 2012-06-15 | 2015-03-04 | 莫茨药物股份两合公司 | 制备基于透明质酸的组合物的方法 |
CN104906030A (zh) * | 2014-03-14 | 2015-09-16 | 台湾生医材料股份有限公司 | 压力敏感性水胶及其使用方法 |
CN104906030B (zh) * | 2014-03-14 | 2018-08-28 | 台湾生医材料股份有限公司 | 压力敏感性水胶及其使用方法 |
CN104086788A (zh) * | 2014-07-17 | 2014-10-08 | 华熙福瑞达生物医药有限公司 | 一种注射用修饰透明质酸钠凝胶 |
CN107223061A (zh) * | 2015-02-13 | 2017-09-29 | 阿勒根工业有限公司 | 用于雕塑、填充或矫正面部特征例如下巴的植入物 |
CN107207784A (zh) * | 2015-02-13 | 2017-09-26 | (株)安道德玛 | 利用交联透明质酸水凝胶的微结构体及其的制造方法 |
US10493160B2 (en) | 2015-02-13 | 2019-12-03 | Endoderma Co., Ltd. | Microstructure using cross-linked hyaluronic acid hydrogel, and method for producing same |
CN105107018B (zh) * | 2015-08-19 | 2018-08-24 | 李媚 | 一种无菌可注射材料的制备方法 |
CN105107018A (zh) * | 2015-08-19 | 2015-12-02 | 李媚 | 一种无菌可注射材料的制备方法 |
CN106074213A (zh) * | 2016-06-24 | 2016-11-09 | 上海建华精细生物制品有限公司 | 用于水光注射的透明质酸钠凝胶及其制备方法和应用 |
WO2019033596A1 (zh) * | 2017-08-16 | 2019-02-21 | 杭州协合医疗用品有限公司 | 制备单相修饰透明质酸钠凝胶的方法 |
CN108261341A (zh) * | 2018-02-12 | 2018-07-10 | 苏州纳晶医药技术有限公司 | 双组份用于纠正皮肤皱纹的美白长效水光针剂 |
CN111068114A (zh) * | 2019-12-26 | 2020-04-28 | 浙江景嘉医疗科技有限公司 | 一种含甘露醇的注射用修饰透明质酸钠凝胶的制备方法 |
CN111068114B (zh) * | 2019-12-26 | 2022-05-03 | 浙江景嘉医疗科技有限公司 | 一种含甘露醇的注射用修饰透明质酸钠凝胶的制备方法 |
CN115944553A (zh) * | 2022-12-07 | 2023-04-11 | 华熙生物科技股份有限公司 | 寡肽在提高交联透明质酸或其盐稳定性中的应用 |
Also Published As
Publication number | Publication date |
---|---|
WO2008068297A1 (fr) | 2008-06-12 |
MX2009005894A (es) | 2009-09-10 |
AU2007328917A1 (en) | 2008-06-12 |
TN2009000223A1 (fr) | 2010-10-18 |
EP2152329A1 (fr) | 2010-02-17 |
FR2909560B1 (fr) | 2012-12-28 |
RU2009125201A (ru) | 2011-01-20 |
IL199002A0 (en) | 2010-02-17 |
KR20090085102A (ko) | 2009-08-06 |
TWI430815B (zh) | 2014-03-21 |
ES2632947T3 (es) | 2017-09-18 |
AR064175A1 (es) | 2009-03-18 |
KR101642622B1 (ko) | 2016-07-25 |
CA2671793A1 (fr) | 2008-06-12 |
KR101642516B1 (ko) | 2016-07-25 |
ZA200903919B (en) | 2010-06-30 |
US20100316683A1 (en) | 2010-12-16 |
UA95660C2 (ru) | 2011-08-25 |
KR20140101018A (ko) | 2014-08-18 |
EP2152329B1 (fr) | 2017-02-15 |
EP2489374A1 (fr) | 2012-08-22 |
TW200836778A (en) | 2008-09-16 |
AU2007328917B2 (en) | 2012-08-02 |
NZ577917A (en) | 2012-01-12 |
MA30978B1 (fr) | 2009-12-01 |
JP5642388B2 (ja) | 2014-12-17 |
RU2448740C2 (ru) | 2012-04-27 |
NO20092465L (no) | 2009-06-30 |
JP2010511454A (ja) | 2010-04-15 |
IL199002A (en) | 2013-01-31 |
BRPI0720176A2 (pt) | 2013-12-24 |
FR2909560A1 (fr) | 2008-06-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN101594892A (zh) | 真皮内注射用透明质酸水凝胶 | |
Requena et al. | Adverse reactions to injectable soft tissue fillers | |
Park et al. | Injectable hydrogels prepared from partially oxidized hyaluronate and glycol chitosan for chondrocyte encapsulation | |
La Gatta et al. | Biophysical and biological characterization of a new line of hyaluronan-based dermal fillers: a scientific rationale to specific clinical indications | |
KR100759091B1 (ko) | 피부 충전제 조성물 | |
Edwards et al. | Review of long-term adverse effects associated with the use of chemically-modified animal and nonanimal source hyaluronic acid dermal fillers | |
Huerta-Ángeles et al. | An effective translation: The development of hyaluronan-based medical products from the physicochemical, and preclinical aspects | |
Baumann et al. | Collagen fillers | |
Kapoor et al. | Treating aging changes of facial anatomical layers with hyaluronic acid fillers | |
CN103732614B (zh) | 结合透明质酸的合成肽聚糖、制备和使用方法 | |
Ibrahim et al. | Characterization of glycidyl methacrylate–Crosslinked hyaluronan hydrogel scaffolds incorporating elastogenic hyaluronan oligomers | |
Carleton et al. | Methacrylic acid-based hydrogels enhance skeletal muscle regeneration after volumetric muscle loss in mice | |
Baek et al. | Facile strategy involving low-temperature chemical cross-linking to enhance the physical and biological properties of hyaluronic acid hydrogel | |
US10117822B2 (en) | Cross-linked hyaluronic acid, process for the preparation thereof and use thereof in the aesthetic field | |
CN102247618A (zh) | 皮肤填充剂组合物 | |
Hahn et al. | The effects of subcutaneously injected novel biphasic cross-linked hyaluronic acid filler: in vivo study | |
Gold et al. | The role of a shelf‐ready, human‐derived, soft tissue injectable adipose matrix for facial volume correction | |
EP3717032A1 (en) | Methods of preventing or treating neurogenic shock | |
Larsen et al. | Evaluation of Hylan B (hylan gel) as soft tissue dermal implants | |
Baumann | Collagen-containing fillers: alone and in combination | |
de Wit et al. | A split‐face comparative performance evaluation of injectable hyaluronic acid‐based preparations HCC and CPM‐HA20G in healthy females | |
CN108853595A (zh) | 一种磷酸钙修饰的交联玻尿酸微球的制备方法 | |
Vrentzos et al. | Hyaluronic acid in modern cosmetic and reconstructive surgery | |
Goldberg | BIOALCAMID® | |
Mallia | Dermal fillers |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1133214 Country of ref document: HK |
|
ASS | Succession or assignment of patent right |
Owner name: MERZ PHARMACEUTICAL CO., LTD. AND JOINT VENTURE Free format text: FORMER OWNER: MERZ CO., LTD. AND JOINT VENTURE Effective date: 20140515 Owner name: MERZ CO., LTD. AND JOINT VENTURE Free format text: FORMER OWNER: PIERRE FABRE DERMO-COSMETIQUE INC. Effective date: 20140515 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20140515 Address after: Germany, Frankfurt am Main Applicant after: Merz pharmaceuticals Limited by Share Ltd. and joint ventures Address before: Swiss El Schwerer Applicant before: Merz Limited by Share Ltd. and joint ventures Effective date of registration: 20140515 Address after: Swiss El Schwerer Applicant after: Merz Limited by Share Ltd. and joint ventures Address before: France's Nigeria - Billancourt Applicant before: PIERRE FABRE DERMO-COSMETIQUE |
|
REG | Reference to a national code |
Ref country code: HK Ref legal event code: WD Ref document number: 1133214 Country of ref document: HK |
|
AD01 | Patent right deemed abandoned |
Effective date of abandoning: 20170201 |
|
C20 | Patent right or utility model deemed to be abandoned or is abandoned |